PKTX.OTC.PinkProtokinetix, INC

Form 4: ProtoKinetix CEO Clarence Smith Acquires Additional Shares in Private Placement

Sentiment:

SEC Form 4 Filing


Clarence Edward Smith, President & CEO of ProtoKinetix, Inc., reports acquisition of additional shares through private placements.

Capital raiseThe document mentions shares purchased in a private placement of the company.This indicates that the company recently raised capital through a private sale of its stock.

Summary

  • Clarence Edward Smith, the President & CEO of ProtoKinetix, Inc. (PKTX), filed a Form 4 detailing changes in beneficial ownership.
  • On March 20, 2024, Smith acquired 666,667 shares of common stock at a price of $0.015 per share.
  • On March 29, 2024, Smith acquired 2,500,000 shares of common stock at a price of $0.01 per share.
  • Following these transactions, Smith directly owns 61,714,444 shares of common stock.
  • Smith also indirectly owns 13,572,649 shares through the Clarence E. Smith Trusts and 1,850,000 shares through his retirement account.
  • Smith holds options to purchase 32,350,000 shares of common stock at an exercise price of $0.028, exercisable on December 6, 2028.
  • Smith also holds warrants to purchase 1,600,000 shares of common stock with an exercise price of $0.05, which expired on March 15, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is a positive sign, but the low prices paid in the private placement could indicate concerns about the company's valuation.

Positives

  • The CEO's purchase of additional shares may signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that management believes the company's stock is undervalued. However, it's important to consider the size of the purchase relative to the insider's existing holdings and the overall market capitalization of the company.

Stakeholder Impact

  • Shareholders may view the CEO's purchase of shares as a positive signal.
  • The private placement could dilute existing shareholders if a large number of shares were issued.

Key Dates

DateDescription
03/15/2024Expiration date of warrants to purchase 1,600,000 shares of common stock.
03/20/2024Smith acquired 666,667 shares of common stock at $0.015 per share.
03/29/2024Smith acquired 2,500,000 shares of common stock at $0.01 per share.
04/15/2024Date of Form 4 filing.
12/06/2028Date stock options become exercisable and expiration date of stock options.

Keywords

ProtoKinetix, PKTX, Clarence Smith, insider trading, beneficial ownership, Form 4, private placement, stock options, warrants

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.